Urogen Pharma(URGN)
$28.10+1.92 (+7.33%)
URGN
Urogen Pharma ownership
$28.10
At close:+1.92 (+7.33%)
Want to see URGN full AI Analyst Report?
Urogen Pharma (URGN) Ownership - Who Owns Urogen Pharma?
677 Followers
Urogen Pharma (URGN) Ownership Overview
- 1.77% Insiders
- 5.60% Mutual Funds
- 53.35% Other Institutional Investors
- 7.51% ETFs
- 31.77% Public Companies and Individual Investors
The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 66.46% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 31.77% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 66.46% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 31.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 23, 2026 | Mark Schoenberg | $2,854,853 | |
| Feb 03, 2026 | Mark Schoenberg | $145,174 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Robert Bender&associates | $1,409,902 | |
| Sep 30, 2026 | Ark Investment Management Llc | $2,204,178 | |
| Sep 30, 2026 | $126,286,247 | ||
| Sep 30, 2026 | Gilder Gagnon Howe & Co Llc. | $1,224,913 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 3,108,202 | Institution | 6.34% | 87,340,476 |
| Ishares | 2,260,672 | Institution | 4.61% | 63,524,883 |
| American Century Mutual Funds, Inc. | 874,981 | Institution | 1.78% | 24,586,966 |
| Fidelity Salem Street Trust | 507,789 | Institution | 1.04% | 14,268,871 |
| Michael Rockefeller | 500,726 | Institution | 1.02% | 14,070,401 |
| Vanguard | 470,752 | Institution | 0.96% | 13,228,131 |
| Vanguard Scottsdale Funds | 420,842 | Institution | 0.86% | 11,825,660 |
| Arie Belldegrun | 408,693 | Insider | 0.83% | 11,484,273 |
| Elizabeth A. Barrett | 326,691 | Insider | 0.67% | 9,180,017 |
| Fidelity | 256,406 | Institution | 0.52% | 7,205,009 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| American Century Mutual Funds, Inc. | 874,981 | Institution | 1.78% | 24,586,966 |
| Fidelity Salem Street Trust | 507,789 | Institution | 1.04% | 14,268,871 |
| Vanguard Scottsdale Funds | 420,842 | Institution | 0.86% | 11,825,660 |
| Tiaa-cref Funds | 158,899 | Institution | 0.32% | 4,465,062 |
| Schwab Capital Trust | 126,848 | Institution | 0.26% | 3,564,429 |
| Vanguard World Fund | 118,428 | Institution | 0.24% | 3,327,827 |
| Valic Co I | 113,987 | Institution | 0.23% | 3,203,035 |
| Clearwater Investment Trust | 67,706 | Institution | 0.14% | 1,902,539 |
| Federated Hermes Mdt Series | 60,521 | Institution | 0.12% | 1,700,640 |
| Russell Investment Co | 46,964 | Institution | 0.10% | 1,319,688 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF, IWM ETF | 1,107,721 | Institution | 2.26% | 29,000,136 |
| iShares Russell 2000 Growth ETF, IWO ETF | 344,632 | Institution | 0.70% | 9,022,466 |
| iShares Biotechnology ETF, IBB ETF | 319,191 | Institution | 0.65% | 8,969,267 |
| Vanguard Russell 2000 ETF, VTWO ETF | 250,505 | Institution | 0.51% | 8,196,524 |
| Fidelity Enhanced Small Cap ETF, FESM ETF | 220,902 | Institution | 0.45% | 5,783,214 |
| SPDR Portfolio Developed World ex-US ETF, SPDW ETF | 194,821 | Institution | 0.40% | 5,100,414 |
| iShares Micro-Cap ETF, IWC ETF | 129,134 | Institution | 0.26% | 3,628,665 |
| Vanguard Health Care ETF, VHT ETF | 120,183 | Institution | 0.25% | 3,932,388 |
| State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR, FR:R2EH ETF | 72,019 | Institution | 0.15% | 1,900,581 |
| ARK Israel Innovative Technology ETF, IZRL ETF | 65,657 | Institution | 0.13% | 1,844,962 |
FAQ
Who Owns Urogen Pharma (URGN)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 66.46% of the company's stock is held by institutional investors, 1.77% is held by insiders, and 31.77% is held by public companies and individual investors.
What percentage of Urogen Pharma (URGN) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 66.46% of Urogen Pharma (URGN) stock is held by institutional investors: 5.60% by mutual funds, 7.51% by ETFs and 53.35% by other institutional investors.
What percentage of Urogen Pharma (URGN) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 31.77% of Urogen Pharma (URGN) stock is held by public companies and individual investors.
Who owns the most shares of Urogen Pharma (URGN)?
BlackRock, Inc. owns the most shares of Urogen Pharma (URGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

